series-c-plus
Stage
2
Investors
About
Exact Therapeutics develops ultrasound-activated drug delivery technology to enhance targeted oncology treatments, focusing on increasing drug uptake in tumors such as pancreatic cancer through their PS101 pro-drug and Acoustic Cluster Therapy platform.
Explore Exact Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.